KKR has agreed to acquire a 54% stake in India-based JB Chemicals & Pharmaceuticals for INR31b (approximately USD415m). The deal, valued at USD500m, will trigger an open offer for an additional 26% that might see KKR owning up to a 64.9% stake in the company. Read more